GC Corporation, one of the world’s premiere manufacturers of professional oral care products, can now confirm that the Chief Administrative Law Judge of the United States International Trade Commission has issued an initial determination in favor of both GC and its subsidiary GC America in Investigation No. 337-TA-1050. While the full ruling remains confidential until a public version of the opinion is approved by the Commission, Chief ALJ Charles E. Bullock has released a public notice of his holding that lithium disilicate products sold by GC under the INITIAL LISI PRESS brand did not violate section 337 of the Tariff Act of 1930 with respect to two U.S. patents asserted by Ivoclar Vivadent AG and its subsidiaries.
“Our team appreciates the diligent and careful work of Chief ALJ Bullock in reaching his conclusions,” said Scott Bradshaw, GC America’s Vice President of Sales. “We are pleased that he found in GC’s favor on all of Ivoclar’s remaining claims at this stage of the Investigation.”
Chief ALJ Bullock’s initial determination is subject to review by the full International Trade Commission, which is expected to issue its final determination in November 2018.
About GC Corporation and GC America
Founded in 1921, GC Corporation is one of the world’s leading manufacturers of innovative materials, devices and equipment designed for use by oral care professionals, laboratories, and consumers. GC America, a subsidiary of GC Corporation for over 25 years, employs nearly 300 people in the United States and traces its own history back to Coe Laboratories, founded in 1928. More information about GC and GC America can be found at www.gcamerica.com For any additional inquires please contact Linda Bellisario, Associate Director of Marketing Communications, at linda.bellisario@gc.dental.
